Table 3.

Outcomes among women diagnosed with gestational diabetes, by screening group

Outcome	Early Screen (n=69)	Routine Screen (n=56)	P	Relative Risk (95% CI)
Primary Composite Outcome*	51 (73.9%)	37 (66.1%)	0.34	1.12 (0.89–1.41)
Secondary Outcomes
Macrosomia	4 (5.9%)	5 (8.9%)	0.73	0.66 (0.19–2.34)
Primary Cesarean	16 (23.2%)	13 (23.2%)	>0.99	1.0 (0.53–1.90)
Gestational Hypertension	14 (20.3%)	8 (14.3%)	0.38	1.42 (0.64–3.14)
Preeclampsia	15 (21.7%)	9 (16.1%)	0.42	1.35 (0.64–2.86)
Without Severe Features	9 (13.0%)	7 (12.5%)	0.93	1.04 (0.41–2.63)
With Severe Features	6 (8.7%)	2 (3.6%)	0.30	2.43 (0.51–11.60)
Hyperbilirubinemia	18 (26.1%)	13 (23.2%)	0.71	1.12 (0.60–2.09)
Shoulder Dystocia	4 (5.8%)	5 (8.9%)	0.51	0.65 (0.18–2.30)
Neonatal Hypoglycemia	7 (10.1%)	8 (14.3%)	0.48	0.71 (0.27–1.84)
Gestational Age at Delivery	36.7 (4.5)	38.7 (1.7)	0.001	..
Any Diabetic Medication	30 (43.5%)	18 (32.1%)	0.20	1.35 (0.85–2.16)
Insulin Medication	11 (15.9%)	3 (5.4%)	0.06	2.98 (0.87–10.15)
Large for Gestational Age	6 (8.7%)	7 (12.5%)	0.49	0.70 (0.25–1.95)